AI assistant
SERA PROGNOSTICS, INC. — Director's Dealing 2021
Jul 22, 2021
34084_dirs_2021-07-21_e0e657be-be68-49cf-8589-40cfda0862a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2021-07-19
Reporting Person: CRITCHFIELD GREGORY C (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-19 | Class A Common Stock | C | 34383 | — | Acquired | 744355 | Direct |
| 2021-07-19 | Class A Common Stock | C | 5253 | — | Acquired | 749608 | Direct |
| 2021-07-19 | Class A Common Stock | C | 11880 | — | Acquired | 761488 | Direct |
| 2021-07-19 | Class A Common Stock | C | 4727 | — | Acquired | 766215 | Direct |
| 2021-07-19 | Class A Common Stock | C | 28730 | — | Acquired | 794945 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-19 | Series A-2 Preferred Stock | $ | C | 34383 | Disposed | Class A Common Stock (34383) | Direct | |
| 2021-07-19 | Series B-1 Preferred Stock | $ | C | 5253 | Disposed | Class A Common Stock (5253) | Direct | |
| 2021-07-19 | Series B-2 Preferred Stock | $ | C | 11880 | Disposed | Class A Common Stock (11880) | Direct | |
| 2021-07-19 | Series C-1 Preferred Stock | $ | C | 4727 | Disposed | Class A Common Stock (4727) | Direct | |
| 2021-07-19 | Series D Preferred Stock | $ | C | 28730 | Disposed | Class A Common Stock (28730) | Direct |
Footnotes
F1: The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date.
F2: Includes 630,832 shares of Class A Common Stock directly held by The Gregory C. Critchfield & Trust. Dr. Critchfield is a Trustee of the Gregory C. Critchfield & Trust. Dr. Critchfield, in such capacity, may be deemed to indriectly beneficially own the securities owned by the trust except to the extent of his pecuniary interest therein, if any.
F3: The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date.
F4: The Issuer's Series B-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $8.32 per share. The Series B-2 Preferred Stock has no expiration date.
F5: The Issuer's Series C-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $12.37 per share. The Series C-1 Preferred Stock has no expiration date.
F6: The Issuer's Series D Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $9.02 per share. The Series D Preferred Stock has no expiration date.
F7: The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021.